Pune Scientists Advance Cancer Treatment with Nanomedicine
Researchers from Agarkar Research Institute, Pune, develop a next-generation nanomedicine platform targeting breast cancer by gene silencing. Their biodegradable nanocarrier leverages MUC-1 receptors for precise tumor targeting, promising an effective alternative to traditional therapies. Published in Advanced Healthcare Materials, the study highlights a dual-gene silencing approach against anti-apoptotic genes MCL-1 and survivin, showcasing significant tumor inhibition with minimal systemic toxicity in studies.
Source: Original Link